Last checked at 19 May 2021 13:56
For immediate release | 19 May 2021 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Result of AGM
Alliance Pharma plc (AIM: APH), the international healthcare group, announces that, at its Annual General Meeting held earlier today, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.
The votes were as follows:
RESOLUTION | VOTES FOR | % | VOTES AGAINST | % | VOTES TOTAL | % OF ISC VOTED | VOTES WITHHELD | |
1 | Report and Accounts | 370,082,283 | 99.99 | 2,000 | 0.01 | 370,084,283 | 69.20 | 365,173 |
2 | Final dividend | 370,448,446 | 100.00 | 0 | 0.00 | 370,448,446 | 69.27 | 1,010 |
3 | Re-elect D. Cook | 364,919,306 | 98.52 | 5,491,119 | 1.48 | 370,410,425 | 69.26 | 39,031 |
4 | Re-elect P. Butterfield | 369,183,937 | 99.67 | 1,229,509 | 0.33 | 370,413,446 | 69.26 | 36,010 |
5 | Re-elect A. Franklin | 368,811,050 | 99.57 | 1,602,396 | 0.43 | 370,413,446 | 69.26 | 36,010 |
6 | Re-elect J. LeCouilliard | 369,062,346 | 99.64 | 1,351,100 | 0.36 | 370,413,446 | 69.26 | 36,010 |
7 | Re-elect R. Jones | 369,069,846 | 99.64 | 1,340,579 | 0.36 | 370,410,425 | 69.26 | 39,031 |
8 | Re-appoint Auditor | 370,335,621 | 99.98 | 82,835 | 0.02 | 370,418,456 | 69.26 | 31,000 |
9 | Remuneration of Auditor | 370,375,357 | 99.99 | 43,099 | 0.01 | 370,418,456 | 69.26 | 31,00 |
10 | Allot shares | 322,454,915 | 87.05 | 47,976,358 | 12.95 | 370,431,273 | 69.26 | 18,183 |
11 | Disapply Pre-emption rights | 310,764,742 | 83.89 | 59,666,531 | 16.11 | 370,431,273
| 69.26 | 18,183 |
The number of the Group's shares in issue as at the date of the meeting was 534,827,034 ordinary shares of 1p each.
Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.
Chris ChrysanthouHead of Legal & Company Secretary19 May 2021
For further information:
Alliance Pharma plc | + 44 (0)1249 466966 |
Peter Butterfield, Chief Executive Officer | |
Andrew Franklin, Chief Financial Officer | |
www.alliancepharma.co.uk | |
Buchanan | + 44 (0)20 7466 5000 |
Mark Court / Sophie Wills / Hannah Ratcliff | |
Numis Securities Limited | + 44 (0)20 7260 1000 |
Nominated Adviser: Freddie Barnfield / Oliver Steele | |
Corporate Broking: James Black |
Investec Bank plc | + 44 (0) 20 7597 5970 |
Corporate Finance: Daniel Adams | |
Corporate Broking: Patrick Robb |
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.
We hold the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused primarily on our Consumer healthcare brands, many of which have significant international or multi-territory reach. Our Prescription Medicines are generally sold in a more limited number of local markets, and most require little or no promotional investment.
Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.
For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com